The making and function of CAR cells

Genetically engineered T cells expressing chimeric antigen receptors (CAR) present a new treatment option for patients with cancer. Recent clinical trials of B cell leukemia have demonstrated a response rate of up to 90%. However, CAR cell therapy is frequently accompanied by severe side effects suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Zabel, Maja, Tauber, Peter A., Pickl, Winfried F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058416/
https://www.ncbi.nlm.nih.gov/pubmed/31181279
http://dx.doi.org/10.1016/j.imlet.2019.06.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7058416/
https://www.ncbi.nlm.nih.gov/pubmed/31181279
http://dx.doi.org/10.1016/j.imlet.2019.06.002

Ejemplares similares